Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan in the ERA JUMP study: was the calculation of disposition index legitimate?
To the Editor: Ahuja et al [1] determined insulin resistance and insulin secretion using HOMA-IR and HOMA of beta cell function (HOMA-β%), respectively, in white men living in the USA and Japanese men in Japan. They elegantly demonstrated that both HOMA-IR and HOMA-β% were significantly higher in the white men compared with the Japanese. In addition, they calculated disposition index (DI, in this case, oral disposition index) as a measure of beta cell function, i.e. HOMA-β% with the degree of insulin resistance being taken into consideration [2]. On the basis that the DI was higher in white than in Japanese people, the authors concluded that the higher DI in white men ‘may partly explain lower susceptibility of white people than Japanese people to developing type 2 diabetes’. We are afraid that there was a serious problem in the calculation of DI, and therefore the conclusion above may not be scientifically sound. The reason for this is as follows. In this study, DI was calculated as HOMA-β% divided by HOMA-IR, which is problematic. HOMA-β% = (FIRI × 20)/(FPG−3.5) [3], where FIRI denotes fasting immunoreactive insulin (μU/ml) and FPG denotes fasting plasma glucose (mmol/l). On the other hand, HOMA-IR = (FIRI × FPG)/22.5 [3]. Therefore, the DI defined by the authors, HOMA-β%/HOMA-IR = [(FIRI × 20)/(FPG−3.5)]/[(FIRI × FPG)/22.5], yields (20 × 22.5)/[(FPG)2 − (FPG × 3.5)] = 450/[(FPG)2 − (FPG × 3.5)] (Fig. 1). As can be seen, the DI thus calculated is simply a function of FPG, not an index of beta cell function. Therefore the DI calculated in the paper of Ahuja et al [1] was naturally higher in whites than in the Japanese individuals because FPG was lower in the former than in the latter. It is obvious that one cannot a priori assume that individuals with a low FPG have robust beta cell function and vice versa. The idea of defining DI as HOMA-β%/HOMA-IR might have arisen from the authors’ understanding that ‘DI is assumed to be hyperbolic (the constant product of insulin sensitivity and insulin secretion) for individuals with the same degree of glucose tolerance,’ which is not always correct [4, 5]. A hyperbolic relationship between indices of insulin sensitivity (SI) and insulin secretion exists for a certain combination of the two, but not for all combinations [4, 5]. There is certainly ethnic diversity, as inferred by Simonson et al [6], such that the relationship between the two in the Japanese population is different from that in white people [5]. It is strongly recommended that the legitimacy of the calculation of DI using any combination of indices of SI (or IR) and insulin secretion should be verified, before utilising the DI value as a measure of beta cell function.
×
…
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan in the ERA JUMP study: was the calculation of disposition index legitimate?
verfasst von
Keishi Yamauchi Yuka Sato Yasuto Nakasone Toru Aizawa
Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.
Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.
Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.
Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.